150.09
2.59 (1.76%)
2.59 (1.76%)
Upgrade to Real-Time
Regular Market
Low
133.20
High
213.94
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Seagen Inc | SGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 2.59 | 1.76% | 150.09 | 12:12:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 145.94 | 144.91 | 150.18 | 147.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 149.99 | 150.09 | 0.10 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,169 | 657,075 | $ 148.82 | $ 97,784,548 | 895,612 | 133.20 - 213.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:12:00 | 141 | $ 150.09 | USD |
Seagen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 27.24B | 181.48M | 65.91M | $ 2.18B | $ 628.73M | 3.30 | 40.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -44.05k | 1.30% |
Seagen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 138.53 | 150.18 | 133.51 | 142.71 | 974,195 | 11.56 | 8.34% |
| 1 Month | 147.26 | 150.18 | 133.20 | 141.98 | 925,969 | 2.83 | 1.92% |
| 3 Months | 157.05 | 159.3499 | 133.20 | 145.76 | 1,038,521 | -6.96 | -4.43% |
| 6 Months | 177.25 | 202.60 | 133.20 | 161.69 | 1,048,394 | -27.16 | -15.32% |
| 1 Year | 162.41 | 213.94 | 133.20 | 165.68 | 1,039,261 | -12.32 | -7.59% |
| 3 Years | 58.67 | 213.94 | 50.71 | 114.17 | 1,003,406 | 91.42 | 155.82% |
| 5 Years | 34.13 | 213.94 | 34.00 | 91.57 | 983,238 | 115.96 | 339.76% |
Seagen Description
| Seagen Inc is a biotech firm focused on developing antibody-drug conjugates. The company's lead product, Adcetris, has received approval for advanced front-line, relapsed/refractory and post-consolidation Hodgkin lymphoma, anaplastic large-cell lymphoma, and two other subtypes of cutaneous T-cell lymphoma. Other approved products include Padcev (bladder cancer) and Tukysa (breast cancer). The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to a number of leading biotechnology and pharmaceutical companies. |
